China NMPA Inspection - Zhejiang Dongou Diagnostic Products Co., Ltd. - April 11, 2017

An unannounced inspection conducted by regulatory authorities has identified significant compliance issues at Zhejiang Dongou Diagnostic Products Co., Ltd. The official report, released on April 11, 2017, by the National Medical Products Administration (NMPA), highlighted that the company's operational practices were not in accordance with the established Good Manufacturing Practice for Medical Devices. Specifically, the inspection revealed notable deficiencies within Zhejiang Dongou Diagnostic Products Co., Ltd.'s quality management system, indicating a failure to meet required industry standards for medical device production. In response to these critical findings, the Zhejiang Provincial Food and Drug Administration, acting under the regulatory framework governing medical device manufacturing, has issued a directive to the company. Zhejiang Dongou Diagnostic Products Co., Ltd. has been formally ordered to address and rectify all identified shortcomings and non-compliances within a prescribed period. This mandated action is crucial for ensuring the company aligns its processes with the necessary regulatory requirements, thereby safeguarding product quality and public health. The inspection underscores the continuous oversight exercised by authorities to uphold manufacturing excellence in the medical device sector.